Lupus érythémateux systémique et lymphopénie : aspects cliniques et physiopathologiques

作者: M. Martin , A. Guffroy , X. Argemi , T. Martin

DOI: 10.1016/J.REVMED.2017.01.005

关键词: GynecologyMedicine

摘要: Resume La lymphopenie est tres frequente au cours du lupus erythemateux systemique (LES), et profonde ( 3 ) dans 10 % des cas. Elle touche principalement les lymphocytes T, notamment CD4 + . Les mecanismes physiopathologiques sont complexes, faisant intervenir anticorps lymphocytotoxiques, un exces d’apoptose, une sensibilite accrue a la lyse par le complement, de meme qu’une repression lymphopoiese phenomenes sequestration lymphocytaire. LES independante autres cytopenies immunosuppresseurs recus. associee l’activite maladie, risque poussee lupique aux sequelles viscerales. Le infectieux bacterien, ), qui constituent probablement sous-groupe avec deficit immunitaire primitif associe necessitant prise en charge specifique.

参考文章(94)
Kondo H, Kadoya A, Iikuni Y, Okada J, Risk factors for Pneumocystis carinii pneumonia in patients with polymyositis/dermatomyositis or systemic lupus erythematosus. The Journal of Rheumatology. ,vol. 23, pp. 1186- 1188 ,(1996)
Kimberly Rp, Ritchlin C, Christian Cl, Porges Aj, Beattie Sl, Patients with systemic lupus erythematosus at risk for Pneumocystis carinii pneumonia. The Journal of Rheumatology. ,vol. 19, pp. 1191- 1194 ,(1992)
D. Gómez-Martín, M. Díaz-Zamudio, G. Vanoye, J. C. Crispín, J. Alcocer-Varela, Quantitative and functional profiles of CD4+ lymphocyte subsets in systemic lupus erythematosus patients with lymphopenia Clinical & Experimental Immunology. ,vol. 164, pp. 17- 25 ,(2011) , 10.1111/J.1365-2249.2010.04309.X
Linda Carli, Chiara Tani, Sabrina Vagnani, Viola Signorini, Marta Mosca, Leukopenia, lymphopenia, and neutropenia in systemic lupus erythematosus: Prevalence and clinical impact—A systematic literature review Seminars in Arthritis and Rheumatism. ,vol. 45, pp. 190- 194 ,(2015) , 10.1016/J.SEMARTHRIT.2015.05.009
R Kadera, J Niebur, W Emlen, Accelerated in vitro apoptosis of lymphocytes from patients with systemic lupus erythematosus. Journal of Immunology. ,vol. 152, pp. 3685- 3692 ,(1994)
Marko Yurkovich, Kateryna Vostretsova, Wenjia Chen, J. Antonio Aviña-Zubieta, Overall and cause-specific mortality in patients with systemic lupus erythematosus: a meta-analysis of observational studies. Arthritis Care and Research. ,vol. 66, pp. 608- 616 ,(2014) , 10.1002/ACR.22173
Insoo Kang, Timothy Quan, Helena Nolasco, Sung-Hwan Park, Myung Sun Hong, Jill Crouch, Eric G. Pamer, John Greg Howe, Joe Craft, Defective Control of Latent Epstein-Barr Virus Infection in Systemic Lupus Erythematosus Journal of Immunology. ,vol. 172, pp. 1287- 1294 ,(2004) , 10.4049/JIMMUNOL.172.2.1287
Adriana Krizova, Janine Ouimet, Janet Pope, Dana Jerome, Deborah Fenlon, Frequency of adverse drug reactions in patients with systemic lupus erythematosus. The Journal of Rheumatology. ,vol. 30, pp. 480- 484 ,(2003)
Amedeo J Cappione, Aimee E Pugh-Bernard, Jennifer H Anolik, Iñaki Sanz, Lupus IgG VH4.34 antibodies bind to a 220-kDa glycoform of CD45/B220 on the surface of human B lymphocytes. Journal of Immunology. ,vol. 172, pp. 4298- 4307 ,(2004) , 10.4049/JIMMUNOL.172.7.4298